GUTS
Biotechnology · Healthcare
Analyst
Ladenburg-Thalman
Equibles does not estimate personal net worth.
Jeffrey Cohen is recorded as Analyst at Ladenburg-Thalman. Jeffrey Cohen has spoken on 18 earnings calls across 11 companies, most recently for Nano-X Imaging Ltd. on September 9, 2026. Those appearances were for Fractyl Health, Inc. (GUTS), Ceribell, Inc. (CBLL), Qt Imaging Holdings, Inc. (QTI), Niagen Bioscience, Inc. (NAGE), Vericel Corp (VCEL) and 6 other companies. The companies whose calls Jeffrey Cohen spoke on are classified in the Healthcare, Consumer Defensive and Industrials sectors.
“What's the latest pro forma share count? Can you repeat the question?”
“I guess, firstly, you did mention Pakistan at the beginning of the call. Could you bring us up to speed on what's going on there?”
“Thanks for taking our questions. just two from our end um could you talk about the uh the contact lens wearers and uh trovaya and perhaps some pickup there from uh v vine dryer and then could you i know it's a bit early but do you expect any um access program sampling programs couponing etc on trovires as you launch…”
“I guess, firstly, could you talk about the the advertising business and advertising revenue a little bit or and drill into that as far as are you wrapping the robots and some of the customers?”
“I guess firstly, Rob, can you talk a little bit more about PRV and a potential priority review for the NB4168? Do you have to request that now or does that request come later and just prior to an NDA or a BLA?”
Ladenburg-Thalman
Analyst
Transcript header (unverified)
GUTS
Biotechnology · Healthcare
CBLL
Medical Devices · Healthcare
Packaged Foods · Consumer Defensive
VCEL
Biotechnology · Healthcare
NNOX
Medical Devices · Healthcare
HROW
Drug Manufacturers - Specialty & Generic · Healthcare
SERV
Integrated Freight & Logistics · Industrials
Education & Training Services · Consumer Defensive
BWAY
Medical Devices · Healthcare